Takeda Pharmaceutical (TAK) Retained Earnings: 2018-2025

  • Takeda Pharmaceutical's Retained Earnings fell 17.08% to $7.8 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $7.8 billion, marking a year-over-year decrease of 17.08%. This contributed to the annual value of $7.8 billion for FY2025, which is 19.18% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Retained Earnings stood at $7.8 billion for Q1 2025, which was down 17.08% from $9.4 billion recorded in Q1 2024.
  • Takeda Pharmaceutical's 5-year Retained Earnings high stood at $14.3 billion for Q1 2021, and its period low was $7.8 billion during Q1 2025.
  • For the 3-year period, Takeda Pharmaceutical's Retained Earnings averaged around $9.6 billion, with its median value being $9.4 billion (2024).
  • Its Retained Earnings has fluctuated over the past 5 years, first rose by 13.37% in 2021, then dropped by 19.43% in 2024.
  • Quarterly analysis of 5 years shows Takeda Pharmaceutical's Retained Earnings stood at $14.3 billion in 2021, then decreased by 10.74% to $12.7 billion in 2022, then dropped by 8.50% to $11.7 billion in 2023, then dropped by 19.43% to $9.4 billion in 2024, then fell by 17.08% to $7.8 billion in 2025.
  • Its Retained Earnings was $7.8 billion in Q1 2025, compared to $9.4 billion in Q1 2024 and $11.7 billion in Q1 2023.